The beneficial effect of the CCR5 Δ32/wt genotype was also found by Brumme et al. [23], who observed improved survival in the median >5 year period after starting the antiretroviral therapy in the univariate analysis adjusted for baseline age, lymphocyte CD4 count, viral load and AIDS defining conditions. Here, CD4 is linked to AIDS.